| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/24/2008 | US20080021027 Novel benzimidazole derivatives |
| 01/24/2008 | US20080021026 Benzothiophene inhibitors of rho kinase |
| 01/24/2008 | US20080021025 Inhibitors of cathepsin s |
| 01/24/2008 | US20080021024 Metalloprotease inhibitors |
| 01/24/2008 | US20080021023 Morpholinyl and pyrrolidinyl analogs |
| 01/24/2008 | US20080021022 (5-(4-Chlorophenyl)isoxazol-4-yl)(3-(pyridin-3-yl)pyrrolidin-1-yl)methanone; enzyme inhibitor of Hydroxysteroid dehydrogenases; treatment of diabetes, obesity |
| 01/24/2008 | US20080021021 Preventive And/Or Remedy For Lower Urinary Tract Diseases Containing Ep4 Agonist |
| 01/24/2008 | US20080021020 2,4-Pyrimidinediamine Compounds And Uses As Anti-Proliferative Agents |
| 01/24/2008 | US20080021019 immunodeficiencies, cancers, cardiovascular diseases, endocrine disorders, Parkinson's disease, metabolic diseases, tumorigenesis, Alzheimer's disease, heart disease, diabetes, neurodegeneration, inflammation, kidney disease, atherosclerosis and airway disease; substituted pyrazine compounds |
| 01/24/2008 | US20080021018 (S)-(-)-1-(4-Fluoroisoquinolin-5-Yl)Sulfonyl-2-Methyl-1,4-Homopiperazine Hydrochloride Dihydrate |
| 01/24/2008 | US20080021017 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 01/24/2008 | US20080021016 Combined Pharmaceutical Composition for the Inhibition of the Decline of Cognitive Functions |
| 01/24/2008 | US20080021015 Use as medicine of a compound restoring active principles in vivo |
| 01/24/2008 | US20080021014 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
| 01/24/2008 | US20080021013 JAK inhibitors for treatment of myeloproliferative disorders |
| 01/24/2008 | US20080021012 3-[4-{6-Substituted Alkanoyl Pyridin-3-Yl}-3-Phenyl]-5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones As Antibacterial Agents |
| 01/24/2008 | US20080021011 Therapeutic compounds |
| 01/24/2008 | US20080021010 2,4-dichloro-N-{[1- (propylsulfonyl)-3-pyridin-2- ylazetidin-3- yl]methyl}benzamide; neurological and psychiatric disorders associated with glycinergic or glutamatergic neurotransmission dysfunction |
| 01/24/2008 | US20080021009 1,2,4-Oxadiazole Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 01/24/2008 | US20080021008 An interpenetrating polymer network preferably of a poly(C1-C4 alkyl (meth)acrylate) bulk polymer and a polyoxyalkylene glycol homopolymer or copolymer additive; controlled release coatings |
| 01/24/2008 | US20080021007 Substituted Porphyrins |
| 01/24/2008 | US20080021006 steroids used as androgen receptor modulators, for the treatment prostate cancer, benign prostatic hyperplasia or breast cancer |
| 01/24/2008 | US20080021005 Pegylated Ion Channel Modulating Compounds |
| 01/24/2008 | US20080021004 Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 01/24/2008 | US20080021003 Extended step-down estrogen regimen |
| 01/24/2008 | US20080021002 Vitamin d compounds used to stabilize kidney transplants |
| 01/24/2008 | US20080021001 Methods For Treating Arthritic Conditions In Dogs |
| 01/24/2008 | US20080021000 Mixtures of and methods of use for polyunsaturated fatty acid-containing phospholipids and alkyl ether phospholipids species |
| 01/24/2008 | US20080020998 Sustained release compositions for the therapeutic management of pain, inflammation and inflammation-associated disorders and prophylactic/ therapeutic methods thereof |
| 01/24/2008 | US20080020997 Glucosamine and Glucosamine/Anti-Inflammatory Mutual Prodrugs, Compositions, and Methods |
| 01/24/2008 | US20080020996 Esters of capsaicin for treating pain |
| 01/24/2008 | US20080020995 Use of Cyclodextrin Complexes Containing Lipoic Acid |
| 01/24/2008 | US20080020994 G proteins in tumor growth and angiogenesis |
| 01/24/2008 | US20080020993 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 01/24/2008 | US20080020992 MULTICISTRONIC CONSTRUCTS WITH siRNA TO INHIBIT TUMORS |
| 01/24/2008 | US20080020991 Methods of Treating, Reducing, or Preventing Autoimmune Conditions |
| 01/24/2008 | US20080020990 Oligo Double-Stranded Rna Inhibiting the Expression of Bcl-2 and Pharmaceutical Composition Containing the Same |
| 01/24/2008 | US20080020989 Cancer, hepatitis C virus infection, mmunomodulators; Acetic acid 2-acetoxymethyl-5-(5-formylamino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-isopropoxycarbonyloxy-tetrahydro-furan-3-yl ester |
| 01/24/2008 | US20080020988 Brain cell- or nerve cell-protecting agents comprising medicinal ginseng |
| 01/24/2008 | US20080020987 Processes for preparing pyrazole-O-glycoside derivatives and novel intermediates of said processes |
| 01/24/2008 | US20080020985 Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof |
| 01/24/2008 | US20080020981 Non-nucleoside reverse transcriptase inhibitors |
| 01/24/2008 | US20080020973 Assays for identification of topoisomerase inhibitors |
| 01/24/2008 | US20080020971 Heptanoic acid derivatives as dipeptidyl peptidase inhibitors |
| 01/24/2008 | US20080020969 36 Human Secreted Proteins |
| 01/24/2008 | US20080020965 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080020964 Test System for the Discovery of Substances for the Promotion of Neuraxonal Growth |
| 01/24/2008 | US20080020462 Atm kinase compositions and methods |
| 01/24/2008 | US20080020076 Methods and Therapies for Potentiating a Therapeutic Action of an Alpha-2 Adrenergic Receptor Agonist and Inhibiting and/or Reversing Tolerance to Alpha-2 Adrenergic Receptor Agonists |
| 01/24/2008 | US20080020073 Use of oligosaccharides to stimulate beta-endorphin production |
| 01/24/2008 | US20080020068 Use Of Trisubstituted Benzopyranones |
| 01/24/2008 | US20080020065 Rapid-melt compositions, methods of making same and method of using same |
| 01/24/2008 | US20080020064 Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear |
| 01/24/2008 | US20080020063 Anti-angiogenic compositions and methods of use |
| 01/24/2008 | US20080020062 Nutritional composition for the treatment of pressure ulcers |
| 01/24/2008 | US20080020059 Compositions and methods for topical treatment of skin infection |
| 01/24/2008 | US20080020058 One or more short interfering RNA, 3-dimethylamino-2-(cholest-5-en-3-beta-oxybutan-4-oxy)-1-(cis,cis-9,12-octadecadienoxy) propane, distearoyl phosphatidylcholine, cholesterol, and 1-[8'-(1,2-Dimyristoyl-3-propanoxy)-carboxamido-3',6'-dioxaoctanyl]carbamoyl-omega-methyl-polyethylene glycol; transfection |
| 01/24/2008 | US20080020057 Personal care composition containing microemulsified wax particles |
| 01/24/2008 | US20080020056 Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 01/24/2008 | US20080020055 Phenylephrine Pharmaceutical Formulations and Compositions for Colonic Absorption |
| 01/24/2008 | US20080020053 Solid Dosage Form Comprising Proton Pump Inhibitor and Suspension Made Thereof |
| 01/24/2008 | US20080020052 Vascular Embolus Of Paclitaxel-Sodium Alginate Microsphere And Its Preparation |
| 01/24/2008 | US20080020050 Medicinal delivery system, and related methods |
| 01/24/2008 | US20080020048 Treatment of Respiratory Disease |
| 01/24/2008 | US20080020046 Pharmaceutical Formulations Comprising Metformin And A Fibrate, And Processes For Obtaining Them |
| 01/24/2008 | US20080020042 Dosage form of sodium ibuprofen |
| 01/24/2008 | US20080020040 Unit dose form for administration of ibuprofen |
| 01/24/2008 | US20080020039 Controlled Release Formulations and Associated Methods |
| 01/24/2008 | US20080020038 Amorphous Aripiprazole and Process for the Preparation thereof |
| 01/24/2008 | US20080020035 Micronutrient formulations and related methods of manufacture |
| 01/24/2008 | US20080020034 Butylphtualide Soft Gel Capsule and Its Preperation Procedure |
| 01/24/2008 | US20080020032 Hydrophobic abuse deterrent delivery system for hydromorphone |
| 01/24/2008 | US20080020031 Methods and compositions for altering mucus secretion |
| 01/24/2008 | US20080020030 Use Of 7-T-Butoxyiminomethylcamptothecin For The Preparation Of A Medicament For The Treatment Of Uterine Neoplasms |
| 01/24/2008 | US20080020028 Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent |
| 01/24/2008 | US20080020026 Hemostatic compositions and methods for controlling bleeding |
| 01/24/2008 | US20080020024 Fast dissolving orally consumable films |
| 01/24/2008 | US20080020021 5-Hydroxysapogenin derivatives with anti-dementia activity |
| 01/24/2008 | US20080020019 Method of decreasing fat deposits and body weight in mammals and birds |
| 01/24/2008 | US20080020018 Combination Products |
| 01/24/2008 | US20080020017 Intraocular Irrigating Solution Having Improved Flow Characteristics |
| 01/24/2008 | US20080020014 Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders |
| 01/24/2008 | US20080020013 Methods of manufacturing and modifying taxane coatings for implantable medical devices |
| 01/24/2008 | US20080020010 Pyridinone diketo acids: inhibitors of HIV replication |
| 01/24/2008 | US20080020006 Stabilisation Of Colorants In Cosmetic And Dermatological Preparations |
| 01/24/2008 | US20080020005 Alpha hydroxy acid sustained release formulation |
| 01/24/2008 | US20080020003 Methods for the delivery of a beta2 agonist to induce bronchodilation and formulations for use in the same |
| 01/24/2008 | US20080019998 Targeted gene delivery for dendritic cell vaccination |
| 01/24/2008 | US20080019997 Therapeutic uses of dunaliella powder |
| 01/24/2008 | US20080019994 Immunization Against Chlamydia Infection |
| 01/24/2008 | US20080019981 administering to proliferating cells in a mammal having a Ras-activated pathway a viruse selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus virus under conditions which result in lysis of neoplasmic cell |
| 01/24/2008 | US20080019980 modified adenovirus containing mutation in or lacks the virus associated RNA gene, modified HSV, vaccinia virus and parapoxvirus; Ras-activated pathway; neoplasm; immunosuppressant |
| 01/24/2008 | US20080019979 HERV-K Antigens, Antibodies, and Methods |
| 01/24/2008 | US20080019978 nicotinic receptor agonist useful for treating metabolic syndrome, dyslipidemia, cardiovascular diseases, disorders of the peripheral and central nervous system, hematological diseases, cancer, inflammation, respiratory diseases, gastrointestinal diseases, diabetes, and non-alcoholic fatty liver diseases |
| 01/24/2008 | US20080019977 administering an integrin or integrin subunit antagonist, leukocyte adhesion-inducing cytokine antagonist or growth factor antagonist, a selectin antagonist or adhesion molecule antagonist |
| 01/24/2008 | US20080019975 Novel Regimens for Treating Diseases and Disorders |
| 01/24/2008 | US20080019971 36P6D5: secreted tumor antigen |
| 01/24/2008 | US20080019970 Methods for preventing, postponing or improving the outcome of spinal device and fusion procedures |
| 01/24/2008 | US20080019969 Methods for Preventing, Postponing or Improving the Outcome of Invasive Spinal Procedures |
| 01/24/2008 | US20080019967 Inflammatory mediator antagonists |